Estimation of normal values of serum transaminases based on liver histology in healthy Asian Indians

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue 4, 2015, Pages 763-766

  Choudhary, Narendra S ^a   Saraf, Neeraj ^a   Saigal, Sanjiv ^a   Gautam, Dheeraj ^b   Lipi, Lipika ^b   Soin, Arvinder S ^a  

^a Medanta Institute of Liver Surgery and Transplantation   (India)

^b NONE   (India)

Author keywords

Alanine aminotransferase; Aspartate aminotransferase; Biopsy; Donor; Histology; Liver

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASIAN INDIAN; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INDIAN; LIVER BIOPSY; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; NORMAL VALUE; ORGAN DONOR; PARAMETERS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; BLOOD; INDIA; LIVER; LIVING DONOR; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; REFERENCE VALUE; SEXUAL DEVELOPMENT; STATISTICS AND NUMERICAL DATA;

ADULT; FEMALE; HUMANS; INDIA; LIVER; LIVING DONORS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; REFERENCE VALUES; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; TRANSAMINASES;

EID: 84924810415     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12836     Document Type: Article

References (22)

1. Siest G, Schiele F, Galteau MM etal. Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. Clin. Chem. 1975; 21: 1077-1087.
2. Sherman KE. Alanine aminotransferase in clinical practice. A review. Arch. Intern. Med. 1991; 151: 260-265.
3. Kaplan MM. Alanine aminotransferase levels: what's normal? Ann. Intern. Med. 2002; 2: 13749-13751.
4. Daniel S, Ben-Menachem T, Vasudevan G, Ma CK, Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am. J. Gastroenterol. 1999; 94: 3010-3014.
5. Alberti A, Morsica G, Chemello L etal. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992; 340: 697-698.
6. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin. Proc. 1980; 55: 434-438.
7. Prati D, Taioli E, Zanella A etal. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann. Intern. Med. 2002; 137: 1-10.
8. Kariv R, Leshno M, Beth-Or A etal. Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study. Liver Int. 2006; 26: 445-450.
9. Kumar S, Amarapurkar A, Amarapurkar D. Serum aminotransferase levels in healthy population from western India. Indian J. Med. Res. 2013; 138: 894-899.
10. Al-hamoudi W, Ali S, Hegab B etal. Revising the upper limit of normal for levels of serum alanine aminotransferase in a Middle Eastern population with normal liver histology. Dig. Dis. Sci. 2013; 58: 2369-2375.
11. Lee JK, Shim JH, Lee HC etal. Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology. Hepatology 2010; 51: 1577-1583.
12. Valadez ER, Favila R, López MM, Uribe M, Sánchez NM. Imaging techniques for assessing hepatic fat content in non alcoholic fatty liver disease. Ann. Hepatol. 2008; 7: 212-220.
13. Mathiesen UL, Franze'n LE, Fryde'n A, Foberg U, Bodemar G. The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients. Scand. J. Gastroenterol. 1999; 34: 85-91.
14. Madan K, Batra Y, Panda SK etal. Role of polymerase chain reaction and liver biopsy in the evaluation of patients with asymptomatic transaminitis: implications in diagnostic approach. J. Gastroenterol. Hepatol. 2004; 19: 1291-1299.
15. Singh SP, Nayak S, Swain M etal. Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey. Indian J. Gastroenterol. 2004; 25: 76-79.
16. Amarapurkar D, Kamani P, Patel N etal. Prevalence of non-alcoholic fatty liver disease: population based study. Ann. Hepatol. 2007; 6: 161-163.
17. Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni CS. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res. Clin. Pract. 2009; 84: 84-91.
18. Chalasani N, Younossi Z, Lavine JE etal. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 2005-2023.
19. Chandalia M, Lin P, Seenivasan T etal. Insulin resistance and body fat distribution in South Asian men compared to Caucasian men. PLoS One 2007; 2: e812.
20. Choudhary NS, Duseja A, Kalra N, Das A, Dhiman RK, Chawla YK. Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFL). Ann. Hepatol. 2012; 1: 478-486.
21. Calvaruso V, Craxi A. Implication of normal liver enzymes in liver disease. J. Viral Hepat. 2009; 16: 529-536.
22. Armstrong MJ, Adams LA, Canbay A, Syn WK. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology 2014; 59: 1174-1197.